| Dr Ashley Ephrem Kanjira, MD | |
|
1000 Medical Center Blvd, Lawrenceville, GA 30046-7694 | |
| (678) 312-4337 | |
| Not Available |
| Full Name | Dr Ashley Ephrem Kanjira |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Experience | 12 Years |
| Location | 1000 Medical Center Blvd, Lawrenceville, Georgia |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528322112 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 074528 (Georgia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Northside Hospital Gwinnett | Lawrenceville, GA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Gwinnett Emergency Specialists Observation Services Llc | 7618140955 | 28 |
News Archive
CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education.
Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence.
Researchers from Tanzania and South Africa, who are part of the Cochrane Infectious Disease Group, hosted at LSTM, have conducted an independent review to assess the effect of intermittent preventive antimalarial treatment (IPT) for children with anaemia living in malaria endemic regions. This is a strategy of giving a treatment dose of antimalarial drugs to children at regular intervals just in case they have become infected.
› Verified 5 days ago
| Entity Name | Northside Emergency Associates, P.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1285686303 PECOS PAC ID: 9335135144 Enrollment ID: O20040426000165 |
News Archive
CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education.
Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence.
Researchers from Tanzania and South Africa, who are part of the Cochrane Infectious Disease Group, hosted at LSTM, have conducted an independent review to assess the effect of intermittent preventive antimalarial treatment (IPT) for children with anaemia living in malaria endemic regions. This is a strategy of giving a treatment dose of antimalarial drugs to children at regular intervals just in case they have become infected.
› Verified 5 days ago
| Entity Name | Gwinnett Emergency Specialists Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437346467 PECOS PAC ID: 0840373619 Enrollment ID: O20080218000080 |
News Archive
CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education.
Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence.
Researchers from Tanzania and South Africa, who are part of the Cochrane Infectious Disease Group, hosted at LSTM, have conducted an independent review to assess the effect of intermittent preventive antimalarial treatment (IPT) for children with anaemia living in malaria endemic regions. This is a strategy of giving a treatment dose of antimalarial drugs to children at regular intervals just in case they have become infected.
› Verified 5 days ago
| Entity Name | Gwinnett Emergency Specialists Observation Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1720373129 PECOS PAC ID: 7618140955 Enrollment ID: O20111101000364 |
News Archive
CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education.
Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence.
Researchers from Tanzania and South Africa, who are part of the Cochrane Infectious Disease Group, hosted at LSTM, have conducted an independent review to assess the effect of intermittent preventive antimalarial treatment (IPT) for children with anaemia living in malaria endemic regions. This is a strategy of giving a treatment dose of antimalarial drugs to children at regular intervals just in case they have become infected.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Ashley Ephrem Kanjira, MD 4575 Admiral Ridge Way Sw, Lilburn, GA 30047-8924 Ph: (770) 876-3523 | Dr Ashley Ephrem Kanjira, MD 1000 Medical Center Blvd, Lawrenceville, GA 30046-7694 Ph: (678) 312-4337 |
News Archive
CSL Behring announced today that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Hizentra (Immune Globulin Subcutaneous [Human]) for the treatment of primary immunodeficiency (PID) and for the treatment of secondary immunodeficiency (SID). Hizentra is now the first and only 20 percent subcutaneous immunoglobulin (SCIg) therapy in the world for the treatment of these conditions, both of which belong to group of rare and serious diseases of the immune system.
A new study from the American Cancer Society finds recent declines in melanoma mortality rates in non-Hispanic Whites in the U.S. mainly reflect declines in those with the highest level of education, and reveals a widening disparity in melanoma mortality rates by education.
Researchers at the University of California, San Diego School of Medicine and Veterans Affairs San Diego Healthcare System report data suggesting that e-cigarettes are toxic to human airway cells, suppress immune defenses and alter inflammation, while at the same time boosting bacterial virulence.
Researchers from Tanzania and South Africa, who are part of the Cochrane Infectious Disease Group, hosted at LSTM, have conducted an independent review to assess the effect of intermittent preventive antimalarial treatment (IPT) for children with anaemia living in malaria endemic regions. This is a strategy of giving a treatment dose of antimalarial drugs to children at regular intervals just in case they have become infected.
› Verified 5 days ago
Amanarh Albert Kisseih, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30045 Phone: 678-442-3317 Fax: 678-442-4416 | |
Dr. Anna Carolyn Nay, DO Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 500 Medical Center Blvd Ste 135, Lawrenceville, GA 30046 Phone: 678-312-3317 | |
Donald Alfred Ruf, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30045 Phone: 678-442-3317 Fax: 678-442-4416 | |
Roy Gilbreath, MD Emergency Medicine Medicare: Not Enrolled in Medicare Practice Location: 1185 Rivershyre Pkwy, Lawrenceville, GA 30043 Phone: 678-591-7640 | |
Tiffany Mckinnie, M.D Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 678-312-4416 | |
Danielle Hines, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30046 Phone: 678-312-3317 | |
Dr. James Lofton Smith Jr., M.D. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 1000 Medical Center Blvd, Lawrenceville, GA 30045 Phone: 678-442-3317 Fax: 678-442-4416 |